Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry-Reference-Cited by-同舟云学术

Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry

Published:2017-03-19 Issue:6 Volume:26 Page:657-665
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Lehto Mika¹^ORCID,Niiranen Jussi¹,Korhonen Pasi²^ORCID,Mehtälä Juha²,Khanfir Houssem²,Hoti Fabian²,Lassila Riitta³,Raatikainen Pekka¹⁴

Affiliation:

1. Department of Cardiology, Heart and Lung Center; University of Helsinki, Helsinki University Hospital; Helsinki Finland

2. EPID Research Oy; Espoo Finland

3. Department of Hematology, Comprehensive Cancer Center; University of Helsinki, Helsinki University Hospital; Helsinki Finland

4. University of Eastern Finland; Jyväskylä Finland

Funder

Helsinki University Hospital District research fund

The Finnish Foundation for Cardiovascular Research

Bristol-Myers Squibb and Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference32 articles.

1. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study;Wolf;Neurology,1978

2. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation;Hart;Ann Intern Med,2007

3. Stroke prevention in atrial fibrillation: a systematic review;Lip;JAMA,2015

4. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC);Kirchhof;Eur Heart J,2016

5. The National Institute for Health and Care Excellence (NICE) nice.org.uk/guidance/cg180

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study;Annals of Medicine;2024-06-14

2. Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case–control study;BMJ Open;2023-11

3. Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database;Clinical Therapeutics;2023-04

4. Pharmacogenetics of warfarin and healthcare costs – Real‐world data analysis;Pharmacoepidemiology and Drug Safety;2022-12-22

5. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation;Journal of Neurology, Neurosurgery & Psychiatry;2022-04-08